HERA Industry days 2025

Type

Conferences and summits

Location

The Egg

Rue Bara 175, 1070 Brussels, Belgium

Subscribe to receive updates

This event has ended.

Practical information

Summary: Participants will gain exclusive insights into HERA’s and EU’s priorities, explore funding opportunities, and engage with leading technical experts. With a strong focus on industry engagement – particularly for SMEs and startups – the event will provide a key platform for knowledge exchange, networking and partnership-building.
By uniting key stakeholders, this first edition will aim to establish the HERA Industry Days as the reference event in Europe to strengthen collaboration and advance towards a more resilient and coordinated European health preparedness ecosystem.
Contact: heraindustrydays@cecoforma.com
When: Mon, 02/06/2025 - 09:00 until
Tue, 03/06/2025 - 18:00
Europe/Brussels
Languages: English

Description

The first edition of HERA Industry Days will take place in Brussels, bringing together leading figures from across the medical countermeasure (MCM) ecosystem—including pharmaceutical companies, biotech firms, SMEs, start-ups, research institutions, and public health authorities.

Participants will have the opportunity to:

Forge partnerships – Connect with key industry players and decision-makers to accelerate MCM innovation.
Gain strategic insights – Understand HERA’s and EU’s core priorities, vision, and funding mechanisms supporting MCM development.
Engage with industry experts – Learn from leading technical specialists on regulatory pathways, production scalability, and EU support tools.
Expand their network – Build lasting connections within Europe’s premier MCM industry event, fostering collaboration across sectors.

The event is a unique opportunity to be at the forefront of Europe's industrial response to cross-border health threats. Stay informed through the HERA Stakeholders Hub, and register to make sure you secure your place.

Agenda

Schedule	Event
08.30	Opening of the doors and registration
09.00 – 09.30	Welcome coffee
09.30 – 09.35	Opening remarks Florika FINK-HOOIJER Director-General of HERA
09.35 – 09.50	Keynote speech Hadja LAHBIB Commissioner for Equality, Preparedness and Crisis Management
09.50 – 11.15	Plenary panel Future proof EU manufacturing: competitive and resilient supply chains for medical countermeasures Panellists: Andras Tivadar Kulja, MEP (EPP, Hungary) Christophe Clergeau, MEP (S&D, France) Emer Cooke, Executive Director, EMA Elisabeth Stampa, Vice President, Medicines for Europe Juan López-Belmonte Encina, EFPIA Board Member & CEO of Rovi Pharmaceuticals
11.15 – 11.45	Coffee break
11.45 - 13.00	Plenary panel Breaking barriers to effective funding for innovative medical countermeasures Panellists: Tim Nguyen, Unit Head, Medical Countermeasures, WHO Magda Chlebus, Executive Director of Science Policy & Regulatory Affairs, EFPIA Sebastien Iva, CEO at Fabentech Marc Gitzinger, President of the Board, BEAM Alliance Hannah Cameron, Adviser to the Europe Director, Gates Foundation Yann Ferrisse, Director, Business Development & Partner Engagement, GARDP
13.00 - 14.25	Networking lunch (and exhibition)
14.25 - 14.30	Keynote speech (video) Olivér VÁRHELYI Commissioner for Health and Animal Welfare
14.30 - 15.45	Plenary panel The role of industry in strategic stockpiling and civil-military preparedness Panellists: Yannick Saintigny, French Alternative Energies and Atomic Energy Commission (CEA) Stephane Martin, General Manager, Senior commercial leader, Bavarian Nordic Anke van Es, Head of Europe for Patient Hospital Monitoring, Royal Phillips Kasper Ernest, Director General, European Healthcare Distribution Association (GIRP) Jakub Smolar, Medical CBRN Defense Head, Swiss Armed Forces Robert Balazs, NATO Support and Procurement Agency (NSPA)
15.45 - 16.15	Coffee break
16.15 - 17.30	Plenary panel Shaping the future of vaccines: progress, challenges, and innovation Panellists: Rino Rappuoli, Project Coordinator for the European Vaccine Hub (SVA) An Vermeersch, Chief Vaccine Programmes and Markets Officer, Gavi Aurélia Nguyen, Deputy CEO CEPI Sibilia Quilici, Executive Director Vaccines Europe Jorrit Van Hoorn, Director of Bilthoven Biologicals Eugenia Puentes Colorado, R&D Director, Zendal Group
17.30 - 17.45	Closing remarks Laurent MUSCHEL Deputy Head of HERA
17.45 - 20.00	Networking reception

Schedule	Event
08.30	Opening of the doors and registration
09.00 – 09.30	Welcome coffee
09.30 – 09.45	Introductory remarks Florika FINK-HOOIJER Director-General of HERA
09.45 – 11.00	Side session 1 - Aquarium Joint procurement: how does it work and future perspectives Moderator:Olivier Girard, HERA 03 Speakers: Ray Longstaff, Director, Commercial Strategy, Pandemic Enterprise, CSL Seqirus David Jauch, Vice President, Governmental Affairs & Public Policy, Fresenius Kabi Ancel-la Santos Quintano, Head of Food, Health and Chemical Safety, BEUC Eirik Sverrisson, The Norwegian Hospital Procurement Trust	Side session 2 - Studio Driving innovation and collaboration for global health preparedness Opening remarks: Erica Gerretsen, INTPA G Moderator: Cecile Billaux, INTPA G4 Speakers: Pauline Beattie, Operations Manager and Scientific Adviser, European & Developing Countries Clinical Trials Partnership (EDCTP) Olufunke Falade, Presidential Initiative for Unlocking the Healthcare Value Chain (PVAC) Jorge Emilio Osorio, CEO Vaxthera Karim Bendhaou, Head of Africa Bureau, Merck
11.00 - 11.30	Coffee break
11.30 - 13.00	Side session 1 - Aquarium MCMs for vector-borne diseases: industry challenges and funding opportunities Moderator:Ana Burgos, HERA 02 Speakers: Isabela Ribeiro, Viral Diseases Cluster Director, DNDi Olivier Jankowitsch, Vice President Governmental Affairs Valneva Anna-Bella Failloux, Head of the Arbovirus and Insect Vectors Unit, Institut Pasteur Lisa Goerlitz, Head of Advocacy DSW, voucher for Dengue and Chikungunya industry partnerships	Side session 2 - Studio Sustainable regulatory pathways for MCM innovation, a focus on SMEs Moderator:Olivier Girard, HERA 03 Speakers: Marco Cavaleri, Head of Health Threats and Vaccines Strategy, EMA Carole Sansoz, Head of Regulatory and Pharmaceutical Affairs, Phaxiam Therapeutics Judith Fernandez, Deputy director, HTA department at Haute Autorité de Santé, France Cornelius Schmaltz, Head of Unit, HERA 02
13.00 - 14.15	Networking lunch (exhibition and speed-matching)
14.15 - 14.30	Keynote speech Jozef SIKELA Commissioner for International Partnerships
14.30 -16.00	Side session 1 - Aquarium Dual-use funding: opportunities and challenges in bridging civil and defence innovation Moderator: Anne Simon, HERA 04 Speakers: Milan Novotny, Project Officer CBRN &Human Factors, EDA Hans De Neef, Strategic Manager, Belgian CBRNe expertise center, Belgian National Crisis Center Luca Fiorani, Policy Officer, DG DEFIS Basile Gorin, Head of Government Affairs, SERB Pharmaceuticals	Side session 2 - Studio EU funding opportunities in EU4Health and Horizon Europe Moderator:Ana Burgos, HERA 02 Speakers: Angelo Marino, Head of Department A – Health and Food, HaDEA Agnes Mathieu, Head of Unit A.2 - EU4Health/SMP Food, HaDEA Florina Telea – Head of Unit A.1 - EU4Health, HaDEA Stephane Hogan, Head of Unit A.3 - Health research, HaDEA
16.00-16.30	Coffee break
16.30-17.30	Side session 1 - Aquarium Advancing diagnostics: scaling production, overcoming industry challenges, and addressing future needs in crises Moderator:Cornelius Schmaltz, HERA 02 Speakers: Jean-Paul Meijinen, Senior Director, Ginkgo Bioworks Netherlands Irek Roslon, CEO Soundcell Jeroen Nieuwenhuis, Nostics Christian Drosten, DURABLE Project	Side session 2 - Studio Scalable manufacturing for crisis preparedness Moderator:Csaba Gali, HERA 03 Speakers: Josep Ferres Corominas, Quality Compliance & Contract Manufacturing Executive Director, HIPRA Gemma Lahuerta, Director of injectable product development and CDMO lead, Reig Joffre Joachim Bug, Head of ZEPAI Karen Van Hoey, Vice President, New Product and LCM Lead, Global Technology & Engineering Dominique Maugeais, Independent Consultant